Cargando…

Visually Evoked Potentials after Panretinal Photocoagulation in Omani Patients with Uncontrolled Diabetes Mellitus

AIM: To report on the changes of latency and amplitudes of the pattern VEP in patients with uncontrolled diabetes mellitus II and I before and after panretinal laser treatment. DESIGN: Single center hospital based comparative study. METHODS: One hundred eyes of patients with proliferative diabetic v...

Descripción completa

Detalles Bibliográficos
Autores principales: Shenoy, Radha, Al-Belushi, Habiba, Al-Ajmi, Sadiqa, Al-Nabhani, Susan Margaret, Ganguly, Shyam Sunder, Bialasiewicz, Alexander A.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038108/
https://www.ncbi.nlm.nih.gov/pubmed/21346837
http://dx.doi.org/10.4103/0974-9233.51992
Descripción
Sumario:AIM: To report on the changes of latency and amplitudes of the pattern VEP in patients with uncontrolled diabetes mellitus II and I before and after panretinal laser treatment. DESIGN: Single center hospital based comparative study. METHODS: One hundred eyes of patients with proliferative diabetic vitreoretinopathy, and HbA1C ≥ 10 percent were subjected to Pattern Visually Evoked Potentials (Medtronic keyopint system, Nicolet) prior to and 4 weeks after PRP. Results were compared to age-matched non-diabetic controls. Chi-Square test, and paired ‘t’ test were used for statistical analysis. RESULTS: Preoperative mean VEP amplitude was 8.35mV±3.71, and not significantly different to the control group (mean 10.51mV±3.34) (chi square test p=1). Mean preoperative P100 latency was 106.93±7.90ms and significantly different to the control group (103.21±7.65ms) (paired t-test p=0.001). After laser treatment, VEP amplitudes decreased in 48/100 eyes (mean total 5.11mV±2.4), and P100 latency increased in 75/100 eyes (mean total 110.47±7.35ms). CONCLUSION: In this study, PRP was followed by a significant decrease in VEP amplitudes in 48 percent and increase in latency in 75 percent of eyes.